Skip to main contentAll experts

Mohammed Gbadamosi

AST PROF

PH-PHARMTHERAPY TRNSL RSCH

Orcid identifier0000-0002-2751-1172 (opens in a new tab)⁠
  • AST PROF
    PH-PHARMTHERAPY TRNSL RSCH

GRANTS

  • GRANT
    Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
    National Institute of Health Od22 Sep 2023 - 31 Jul 2028
    Active
  • GRANT
    Pharmacogenomic Drivers of Efficacy in Anti-CD33 Immunotherapeutic Treatment Strategies
    American Foundation for Pharm Education29 Jul 2020 - 31 Aug 2021
    Expired